Frequently Asked Questions
The factors such as an increase in cancer cases and rising demand for assays are acting as the major drivers for the apoptosis stimulant market.
Cipla Inc. (India), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Bristol-Myers Squibb Company (U.S.), GSK plc (U.K.), CASI Pharmaceuticals Inc. (U.S.), Anavex Life Sciences Corp (U.S.), Aeterna Zentaris (U.S.).
Asia-Pacific dominates the market due to increased government initiatives and rapidly increasing disposable income.
North America has been witnessing positive growth in the apoptosis stimulant market throughout the forecast period due to the rise in cancer cases, favorable government policies, and advanced healthcare facilities.
